Skip to main content

Everspin Reports Unaudited Third Quarter 2021 Financial Results

The Company Reports its Best Quarter in Company History

Everspin Technologies, Inc. (NASDAQ: MRAM), the market leader in MRAM, today announced preliminary unaudited financial results for the third fiscal quarter of 2021.

Third Quarter 2021 Highlights

  • Q3’21 revenue increased 25% and $2.9 million from $11.9 million in the prior quarter to $14.8 million. This is an increase of 46.5% compared to $10.1 million of revenue in Q3’20.
  • The Company reported record net income of $880k for Q3’21, resulting in year-to-date net income for FY2021 of $676k. This is compared to a net loss reported of $3.9 million for Q3’20, with a prior year-to-date net loss of $6.9 million for the nine months ended September 30, 2020.
  • Ended Q3’21 with cash and equivalents of $14.6 million; which is an increase from $14.2 million reported in the prior quarter.

“Everspin’s Q3 results are a reflection of our team’s ability to deliver on growing product revenue and monetizing our IP,” stated Darin Billerbeck, Everspin’s Executive Chairman and Interim CEO.

Third Quarter 2021 Results

Total revenue for the third quarter of 2021 was $14.8 million, an increase of 25% from the $11.85 million reported last quarter. This is an increase of 46.5% compared to $10.1 million of revenue in Q3’20.

MRAM product sales in the third quarter, which includes both Toggle and STT-MRAM revenue, was $12 million vs $10.2 million in the prior quarter and $9.6 million in Q3’20. In Q3’21, the company entered into an intellectual property (“IP”) monetization deal worth $5.25 million. $1.3 million in revenue was recognized in Q3’21 and the remaining $3.95 million of revenue is expected to be recognized in Q4’21. Licensing, Royalties and Other revenue in the quarter was $2.8 million compared to $1.7 million in the previous quarter and $0.5 million in the prior year period. The increase in total revenue is due to strong Toggle sales, revenue recognition from a U.S. Government RAD-Hard program entered into earlier this year and the IP monetization deal note above.

Gross margin for the third quarter of 2021 was 57.1%, compared to 60.8% in the prior quarter and 23.0% in the third quarter of 2020.

GAAP operating expenses for the third quarter of 2021 increased to $7.4 million, compared to $6.7 million in the second quarter of 2021 primarily due to increases in research and development, sales and marketing and administrative costs. This is compared to operating expenses of $6.0 million in the third quarter of 2020. GAAP operating expenses in the third quarter of 2021 included $1.03 million of stock-based compensation, compared to $704k in the prior quarter and $910k in the third quarter of 2020.

GAAP net income for the third quarter of 2021 was $880k, or $0.05 per share, based on 19.5 million weighted-average basic common shares outstanding. This compares to a net income of $256k, or $0.01 per basic share, in the second quarter of 2021 and a net loss of $3.9 million, or ($0.21) per basic share, in the third quarter of 2020.

Adjusted EBITDA for the third quarter of 2021 improved to $2.5 million, compared to $1.5 million in the prior quarter and a negative ($2.0) million in the third quarter of 2020.

Cash and cash equivalents as of September 30, 2021, were $14.6 million, compared to $14.2 million in the prior quarter, and an increase from $13.9 million at the end of the third quarter of 2020.

Business Outlook

For the fourth quarter 2021, Everspin expects total revenue in a range of $16.25 million to $17.25 million which, at the mid-point of $16.75 million, represents a 13.2% increase over $14.8 million third quarter 2021 actuals. The revenue range reflects expected product revenue growth as well as the remaining $3.95 million of revenue expected to be recognized for the IP monetization deal discussed above. Everspin expects a GAAP net income per basic share of between $0.02 and $0.08, primarily driven by expenses related to next generation 28nm STT MRAM product and price increases from our suppliers.

This outlook is dependent on Everspin's current expectations, which may be impacted by, among other things, evolving external conditions, such as the resurgence of COVID-19 and its variants, local safety guidelines, worsening impacts due to supply chain constraints or interruptions, and the other risk factors described in Everspin's filings with the SEC, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2020, its Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") during 2021, as well as in its subsequent filings with the SEC.

MRAM Solution Designed into Lucid Air Luxury Electric Vehicles

In June 2021, Everspin announced MRAM Solutions will be designed into Lucid Air Luxury Electric Vehicles. Everspin believes the adoption of its MRAM technology in the Lucid Air – which delivers new benchmarks in range, efficiency, and power for electric vehicles – is a strong endorsement of the value of persistent, non-volatile memory that does not have the traditional wear-out problems associated with alternative memory technologies.

Use of Non-GAAP Financial Measures

We supplement the reporting of our financial information determined under generally accepted accounting principles in the United States of America (GAAP) with Adjusted EBIDTA, which is a non-GAAP financial measure. We define Adjusted EBITDA as net income (loss) adjusted for interest expense, taxes, depreciation and amortization, stock- based compensation expense, and restructuring costs if any.

Our management and board of directors use Adjusted EBIDTA to understand and evaluate our operating performance and trends, to prepare and approve our annual budget and to develop short-term and long-term operating and financing plans. Accordingly, our management believes that this non-GAAP measure provide useful information for investors in understanding and evaluating our operating results in the same manner as our management and our board of directors, as well as facilitating comparisons of our operating performance on a period-to-period basis.

Non-GAAP financial measures, including Adjusted EBIDTA, should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. Moreover, other companies may define non-GAAP measures differently, which limits the usefulness of these measures for comparisons with such other companies. We encourage investors to review our financial statements and publicly- filed reports in their entirety and not to rely on any single financial measure.

Conference Call

Everspin will host a conference call for analysts and investors on Thursday, November 11 at 5:00 p.m. Eastern Time. Interested participants can access the call by dialing 1-844-889-7788 and providing passcode 2075705. International callers may join the call by dialing +1-404-537-3406, using the same code. The call will also be available as a live and archived webcast in the Investor Relations section of the company’s website at investor.everspin.com.

A telephone replay of the conference call will be available approximately two hours after the call through November 19, 2021. The replay can be accessed by dialing 1-855-859-2056 and using the passcode 2075705. International callers should dial +1-404-537-3406 and enter the same passcode at the prompt.

About Everspin Technologies

Everspin Technologies, Inc. is the world’s leading provider of Magnetoresistive RAM (MRAM). Everspin MRAM delivers the industry’s most robust, highest performance non-volatile memory for Industrial IoT, Data Center, and other mission-critical applications where data persistence is paramount. Headquartered in Chandler, Arizona, Everspin provides commercially available MRAM solutions to a large and diverse customer base. For more information, visit www.everspin.com. NASDAQ: MRAM.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements regarding future results that involve risks and uncertainties that could cause actual results or events to differ materially from the expectations disclosed in the forward-looking statements, including, but not limited to the statements made under the caption “Business Outlook.” Forward-looking statements are identified by words such as “believe”, “will”, “may”, “estimate”, “continue”, “anticipate”, “intend”, “should”, “plan”, “expect”, “predict”, “could”, “potentially" or the negative of these terms or similar expressions. These include, but are not limited to, our future plans, strategies, objectives, expectations, intentions and financial performance, including the outlook and guidance for fourth quarter 2021 results, and the assumptions that underlie these statements. Actual results could differ materially from these forward-looking statements as a result of certain risks and uncertainties, including, without limitation, the risks set forth under the caption “Risk Factors” in Everspin’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on March 4, 2021, its Quarterly Reports on Form 10-Q filed with the SEC during 2021, as well as in its subsequent filings with the SEC. Any forward- looking statements made by Everspin in this press release speak only as of the date on which they are made and subsequent events may cause these expectations to change. Everspin disclaims any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise.

EVERSPIN TECHNOLOGIES, INC.

Condensed Balance Sheets

(In thousands, except share and per share amounts)

(Unaudited)

 

 

 

 

 

 

 

 

 

September 30,

 

December 31,

 

 

2021

 

 

2020

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

14,558

 

 

$

14,599

 

Accounts receivable, net

 

 

10,629

 

 

 

7,607

 

Inventory

 

 

6,668

 

 

 

5,721

 

Prepaid expenses and other current assets

 

 

337

 

 

 

270

 

Total current assets

 

 

32,192

 

 

 

28,197

 

Property and equipment, net

 

 

951

 

 

 

1,946

 

Right-of-use assets

 

 

1,270

 

 

 

2,313

 

Other assets

 

 

488

 

 

 

73

 

Total assets

 

$

34,901

 

 

$

32,529

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

2,663

 

 

$

2,224

 

Accrued liabilities

 

 

2,523

 

 

 

2,232

 

Deferred revenue

 

 

1,382

 

 

 

 

Current portion of long-term debt

 

 

3,364

 

 

 

4,242

 

Operating lease liabilities

 

 

1,011

 

 

 

1,508

 

Other liabilities

 

 

36

 

 

 

31

 

Total current liabilities

 

 

10,979

 

 

 

10,237

 

Long-term debt, net of current portion

 

 

2,100

 

 

 

3,748

 

Operating lease liabilities, net of current portion

 

 

268

 

 

 

903

 

Long-term income tax liability

 

 

229

 

 

 

229

 

Total liabilities

 

$

13,576

 

 

$

15,117

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of September 30, 2021 and December 31, 2020

 

 

 

 

 

 

Common stock, $0.0001 par value per share; 100,000,000 shares authorized; 19,552,125 and 19,031,556 shares issued and outstanding as of September 30, 2021 and December 31, 2020

 

 

2

 

 

 

2

 

Additional paid-in capital

 

 

177,821

 

 

 

174,584

 

Accumulated deficit

 

 

(156,498

)

 

 

(157,174

)

Total stockholders’ equity

 

 

21,325

 

 

 

17,412

 

Total liabilities and stockholders’ equity

 

$

34,901

 

 

$

32,529

 

EVERSPIN TECHNOLOGIES, INC.

Condensed Statements of Operations and Comprehensive Income (Loss)

(In thousands, except share and per share amounts)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

Product sales

 

$

12,037

 

 

$

9,577

 

 

$

31,292

 

 

$

30,139

 

 

Licensing, royalty, patent, and other revenue

 

 

2,758

 

 

 

543

 

 

 

5,631

 

 

 

1,915

 

 

Total revenue

 

 

14,795

 

 

 

10,120

 

 

 

36,923

 

 

 

32,054

 

 

Cost of product sales

 

 

6,043

 

 

 

7,763

 

 

 

14,629

 

 

 

19,009

 

 

Cost of licensing, royalty, patent, and other revenue

 

 

304

 

 

 

28

 

 

 

665

 

 

 

174

 

 

Total cost of sales

 

 

6,347

 

 

 

7,791

 

 

 

15,294

 

 

 

19,183

 

 

Gross profit

 

 

8,448

 

 

 

2,329

 

 

 

21,629

 

 

 

12,871

 

 

Operating expenses:1

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

3,105

 

 

 

2,579

 

 

 

8,901

 

 

 

8,383

 

 

General and administrative

 

 

2,996

 

 

 

2,549

 

 

 

8,177

 

 

 

7,797

 

 

Sales and marketing

 

 

1,272

 

 

 

912

 

 

 

3,304

 

 

 

3,071

 

 

Total operating expenses

 

 

7,373

 

 

 

6,040

 

 

 

20,382

 

 

 

19,251

 

 

Income (loss) from operations

 

 

1,075

 

 

 

(3,711

)

 

 

1,247

 

 

 

(6,380

)

 

Interest expense

 

 

(165

)

 

 

(157

)

 

 

(461

)

 

 

(501

)

 

Other (expense) income, net

 

 

(8

)

 

 

(3

)

 

 

(35

)

 

 

60

 

 

Net income (loss) before income taxes

 

 

902

 

 

 

(3,871

)

 

 

751

 

 

 

(6,821

)

 

Income tax expense

 

 

(22

)

 

 

(24

)

 

 

(75

)

 

 

(100

)

 

Net income (loss) and comprehensive income (loss)

 

$

880

 

 

$

(3,895

)

 

$

676

 

 

$

(6,921

)

 

Net income (loss) per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.05

 

 

$

(0.21

)

 

$

0.03

 

 

$

(0.37

)

 

Diluted

 

$

0.04

 

 

$

(0.21

)

 

$

0.03

 

 

$

(0.37

)

 

Weighted average common shares used to compute net income (loss) per common share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

19,511,132

 

 

 

18,942,163

 

 

 

19,296,241

 

 

 

18,705,149

 

 

Diluted

 

 

19,912,918

 

 

 

18,942,163

 

 

 

19,787,889

 

 

 

18,705,149

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1Operating expenses include stock-based compensation as follows:

 

Research and development

 

$

428

 

 

$

182

 

 

$

874

 

 

$

538

 

 

General and administrative

 

 

434

 

 

 

657

 

 

 

1,224

 

 

 

1,888

 

 

Sales and marketing

 

 

165

 

 

 

71

 

 

 

376

 

 

 

207

 

 

Total stock-based compensation

 

$

1,027

 

 

$

910

 

 

$

2,474

 

 

$

2,633

 

 

EVERSPIN TECHNOLOGIES, INC.

Reconciliation of Adjusted EBITDA

(In thousands)

(Unaudited)

 

 

Three Months Ended

 

 

September 30,

2021

 

June 30,

2021

 

March 31,

2021

 

September 30,

2020

Adjusted EBITDA reconciliation:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

880

 

$

256

 

$

(460

)

 

$

(3,895

)

Depreciation and amortization

 

 

361

 

 

373

 

 

383

 

 

 

799

 

Stock-based compensation expense

 

 

1,027

 

 

704

 

 

743

 

 

 

910

 

Interest expense

 

 

165

 

 

144

 

 

152

 

 

 

157

 

Income tax expense

 

 

22

 

 

44

 

 

9

 

 

 

24

 

Adjusted EBITDA

 

$

2,455

 

$

1,521

 

$

827

 

 

$

(2,005

)

 

 

 

 

 

 

 

 

 

 

 

 

 

EVERSPIN TECHNOLOGIES, INC.

Condensed Statement of Cash Flows

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30,

 

 

 

2021

 

2020

 

Cash flows from operating activities

 

 

 

 

 

 

 

Net income (loss)

 

$

676

 

 

$

(6,921

)

 

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

1,117

 

 

 

1,611

 

 

Stock-based compensation

 

 

2,474

 

 

 

2,633

 

 

Non-cash warrant revaluation

 

 

5

 

 

 

2

 

 

Non-cash interest expense

 

 

274

 

 

 

231

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

 

(3,022

)

 

 

(2,368

)

 

Inventory

 

 

(947

)

 

 

1,690

 

 

Prepaid expenses and other current assets

 

 

(67

)

 

 

440

 

 

Other assets

 

 

(175

)

 

 

 

 

Accounts payable

 

 

656

 

 

 

(31

)

 

Accrued liabilities

 

 

655

 

 

 

(692

)

 

Deferred revenue

 

 

1,382

 

 

 

 

 

Lease liabilities

 

 

(90

)

 

 

(132

)

 

Net cash provided by (used in) operating activities

 

 

2,938

 

 

 

(3,537

)

 

Cash flows from investing activities

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(578

)

 

 

(307

)

 

Net cash used in investing activities

 

 

(578

)

 

 

(307

)

 

Cash flows from financing activities

 

 

 

 

 

 

 

Payments on long-term debt

 

 

(2,800

)

 

 

 

 

Payments on finance lease obligation

 

 

 

 

 

(6

)

 

Proceeds from exercise of stock options and purchase of shares in employee stock purchase plan

 

 

399

 

 

 

1,206

 

 

Proceeds from issuance of common stock in at-the-market offering, net of issuance costs

 

 

 

 

 

2,084

 

 

Net cash (used in) provided by financing activities

 

 

(2,401

)

 

 

3,284

 

 

Net decrease in cash and cash equivalents

 

 

(41

)

 

 

(560

)

 

Cash and cash equivalents at beginning of period

 

 

14,599

 

 

 

14,487

 

 

Cash and cash equivalents at end of period

 

$

14,558

 

 

$

13,927

 

 

Supplementary cash flow information:

 

 

 

 

 

 

 

Interest paid

 

$

178

 

 

$

271

 

 

Operating cash flows paid for operating leases

 

$

1,212

 

 

$

1,298

 

 

Financing cash flows paid for finance leases

 

$

 

 

$

6

 

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

Increase of right-of-use asset and lease liability due to lease modification

 

$

 

 

$

545

 

 

Purchases of property and equipment in accounts payable and accrued liabilities

 

$

 

 

$

8

 

 

Bonus settled in shares of common stock

 

$

364

 

 

$

315

 

 

Issuance of warrant with debt

 

$

 

 

$

152

 

 

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.